Vonoprazan Triple Therapy Most Cost-Effective for H pylori: Study
In the United States, vonoprazan triple therapy has significant health and economic benefits relative to other first-line H pylori eradication regimens, with rifabutin triple therapy a close second.
Source: medscape.com